Loading...
Measurable Residual Disease Detected by Multiparameter Flow Cytometry and Sequencing Improves Prediction of Relapse and Survival in Acute Myeloid Leukemia
The clinically ideal time point and optimal approach for the assessment of measurable residual disease (MRD) in patients with acute myeloid leukemia (AML) are still inconclusive. We investigated the clinical value of multiparameter flow cytometry-based MRD (MFC MRD) after induction (n = 492) and two...
Saved in:
| Published in: | Front Oncol |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Frontiers Media S.A.
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8173083/ https://ncbi.nlm.nih.gov/pubmed/34094982 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.677833 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|